Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

20.78
Delayed Data
As of Jul 31
 +0.39 / +1.91%
Today’s Change
3.10
Today|||52-Week Range
26.80
+106.36%
Year-to-Date

Today’s Trading

Previous close20.39
Today’s open20.25
Day’s range19.79 - 21.00
Volume550,800
Average volume (3 months)818,678
Market cap$753.6M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+10.96%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+731.25%
P/E ratioNM
Price/Sales70.24
Price/Book6.92

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...-0.83-2.61%
KPTIKaryopharm Therapeut...+0.44+2.19%
AMPHAmphastar Pharmaceut...+0.51+3.24%
SGNTSagent Pharmaceutica...-0.30-1.21%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$3.8M
Annual profit (last year)-$34.7M
Net profit margin-906.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Financial Officer, CAO &
VP-Finance
Douglas J. Langston
Corporate headquarters
San Diego, California

Forecasts